DK0753300T3 - Anvendelse af steroider med antioxidative egenskaber til fremstilling af farmaceutiske præparater til medikamentøs substitu - Google Patents

Anvendelse af steroider med antioxidative egenskaber til fremstilling af farmaceutiske præparater til medikamentøs substitu

Info

Publication number
DK0753300T3
DK0753300T3 DK96110339T DK96110339T DK0753300T3 DK 0753300 T3 DK0753300 T3 DK 0753300T3 DK 96110339 T DK96110339 T DK 96110339T DK 96110339 T DK96110339 T DK 96110339T DK 0753300 T3 DK0753300 T3 DK 0753300T3
Authority
DK
Denmark
Prior art keywords
steroids
substitutes
medicinal
preparation
antioxidant properties
Prior art date
Application number
DK96110339T
Other languages
English (en)
Inventor
Michael Prof Dr Oettel
Wolfgang Prof Dr Roemer
Doris Dr Huebler
Jens Schroeder
Sigfrid Prof Dr Schwarz
Peter Dr Droescher
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Application granted granted Critical
Publication of DK0753300T3 publication Critical patent/DK0753300T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96110339T 1995-07-08 1996-06-27 Anvendelse af steroider med antioxidative egenskaber til fremstilling af farmaceutiske præparater til medikamentøs substitu DK0753300T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19524937A DE19524937A1 (de) 1995-07-08 1995-07-08 Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen und zur medikamentösen Substitution beim Mann

Publications (1)

Publication Number Publication Date
DK0753300T3 true DK0753300T3 (da) 2000-03-27

Family

ID=7766353

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96110339T DK0753300T3 (da) 1995-07-08 1996-06-27 Anvendelse af steroider med antioxidative egenskaber til fremstilling af farmaceutiske præparater til medikamentøs substitu

Country Status (7)

Country Link
EP (1) EP0753300B1 (da)
JP (1) JP2765822B2 (da)
AT (1) ATE184795T1 (da)
DE (2) DE19524937A1 (da)
DK (1) DK0753300T3 (da)
ES (1) ES2138272T3 (da)
GR (1) GR3032191T3 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877169A (en) * 1993-11-05 1999-03-02 University Of Florida Research Foundation, Inc. Methods of treatment of ischemic damage
DE19821831A1 (de) * 1998-05-15 1999-11-18 Jenapharm Gmbh Pharmazeutische Präparate zur gezielten Substitution des Estrogenmangels im Zentralnervensystem
IL137727A0 (en) * 1998-02-20 2001-10-31 Jenapharm Gmbh Pharmaceutical preparations for supplementing oestrogen deficiency
US6245756B1 (en) 1998-02-27 2001-06-12 Jenapharm Gmbh & Co. Kg Pharmaceutical preparations for treatment of estrogen deficiency in the central nervous system
DE19915576A1 (de) * 1999-03-30 2000-10-05 Jenapharm Gmbh Equileninderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6326365B1 (en) 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
US6339078B1 (en) 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
US7304171B2 (en) 2004-05-27 2007-12-04 Migenix Corp. Compounds and methods for cytoprotection
CN119055659A (zh) * 2024-09-03 2024-12-03 南通大学 17α雌二醇或其化学修饰衍生物在制备预防和/或治疗男性性腺功能低下的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626061A (en) * 1967-09-08 1971-12-07 Upjohn Co Compositions comprising 7{60 -methyl-17{60 -lkylated estradiols
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
DE4338314C1 (de) * 1993-11-10 1995-03-30 Jenapharm Gmbh Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen

Also Published As

Publication number Publication date
EP0753300B1 (de) 1999-09-22
DE19524937A1 (de) 1997-01-09
DE59603130D1 (de) 1999-10-28
EP0753300A1 (de) 1997-01-15
JPH09100292A (ja) 1997-04-15
GR3032191T3 (en) 2000-04-27
ES2138272T3 (es) 2000-01-01
ATE184795T1 (de) 1999-10-15
JP2765822B2 (ja) 1998-06-18

Similar Documents

Publication Publication Date Title
NL194577B (nl) Preparaat voor de lang aanhoudende en gecontroleerde afgifte van medicamenteuze stoffen.
DE3750431D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
DK0532862T3 (da) Anvendelse af rapamycin til fremstilling af et lægemiddel til behandling af øjeninflammation
FI935306A0 (fi) Anvaendning av renade, ytmodifierande aemnen foer att hindra aggregation av partiklar under sterilisation
DE59007178D1 (de) Verwendung alkylierter Polyethylenimine als gallensäureadsorbierende Arzneimittel sowie pharmazeutische Präparate.
DE3769379D1 (de) Entzuendungshemmende wirkstoffe, pharmazeutische zusammensetzungen und verfahren zur bekaempfung von entzuendungen.
DE69323538D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Wärmeschäden beim Menschen und bei warmblütigen Säugetieren
DK0443224T3 (da) Anvendelse af thrombospondin til fremskyndelse af sårheling
EP0569862A3 (en) Self-adhesive medical sheet and medical preparation.
ITRM920270A0 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
ES2101230T3 (es) Nuevos derivados de sustancias anti-inflamatorias, analgesicas y/o antipireticas no estereoideas, su uso y formulaciones farmaceuticas que las contienen.
DK0744957T3 (da) Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A
DE69726007D1 (de) Prodrogs und analoga von camptothecin und deren verwendung als arzneimittel
BR9205642A (pt) Composiçao farmacêutica, compreendo pelo menos uma quinona, e composiçao para fabricaçao de medicamento
DE59603130D1 (de) Verwendung von Steroiden mit antioxidativen Eigenschaften zur Herstellung von pharmazeutischen Präparaten zur medikamentösen Substitution beim Mann
DE59409205D1 (de) Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
DE69920418D1 (de) Arzneimittel gegen hepatitis
FI972949A0 (fi) Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmenetelmiä
MX9100357A (es) Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion
DE69706241D1 (de) Pharmazeutische Zusammensetzung zur Behandlung der Leukämie enthaltend 9-cis-Retinoinsäure-alpha-Tocopherolester
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
EP0544802A4 (en) Methods and compositions for treating t-cell mediated diseases
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
ATE189395T1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
ES2054029T3 (es) Formulacion de acetato de flecainida con liberacion controlada.